Latest #Zepbound News
Ozempic Zepbound Eye Risk Warnings Issued by FDA on Monday
FDA issues Ozempic Zepbound Eye Risk Warnings on Monday, saying GLP-1 drugs may carry...
CVS to restore Zepbound coverage on standard drug plans Oct. 1
CVS Health will put Zepbound back on standard CVS Caremark plans Oct. 1, alongside Fo...
Weight Loss Results Retatrutide Top 28.3% in Eli Lilly Trial
Weight loss results retatrutide showed up to 28.3% loss over 80 weeks in an Eli Lilly...